Inflammatory Breast Cancer - RAD174B

Inflammatory Breast Cancer

by Brittani Zurek, PharmD
RAD174B
(5.0 / 1 ratings )

This course is credentialed for:
Radiologic Technology (0.75 CE Credit)

ONLINE
Price: $10.00
CE-PRO Price: $5.00

Summary:

Inflammatory breast cancer accounts for 2% to 6% of all breast cancer cases in the United States. Although it is relatively rare, it is the most lethal form of breast cancer. Mammograms of women with inflammatory breast cancer often show architectural distortion and skin thickening. Most women with inflammatory breast cancer also have regional lymph node metastases at initial presentation that can be seen via ultrasound. Biopsies are needed to confirm the presence of invasive breast cancer. Confirmed cases of inflammatory breast cancer are treated with trimodal therapy which includes primary systemic chemotherapy, surgery, and radiotherapy. Chemotherapy should consist of a taxane and anthracycline. Hormonal therapy and targeted therapies may also be used depending on the tumor expression. Pharmacists can help improve survival for this devastating disease by recommending appropriate treatment options and discussing potential toxicities with the healthcare professional team.

Objectives:

The goal of this course is to provide pharmacists, physicians, and imaging technologists with a comprehensive overview of inflammatory breast cancer and present the latest information about its characteristics and treatment. After completing the course, you will be able to:
  • Recognize the epidemiology of inflammatory breast cancer and its risk factors.
  • Identify the clinical characteristics of inflammatory breast cancer.
  • Recall methods to confirm the presence of inflammatory breast cancer.
  • Identify pharmacotherapy options used in the treatment of inflammatory breast cancer.
 

 
Accreditation Information
 
This course is intended for an interprofessional audience, including pharmacists, imaging and radiation therapists, and physicians.
 
Imaging and radiation therapists: Take this version of the course to ensure you receive appropriate credit.
 
For the version accredited or approved for another profession, go to your specific profession at www.ContinuingEducation.com. If you have a CE Direct login ID and password (generally provided by your employer), please log in as you normally would at CEDirect.ContinuingEducation.com and search for this topic title.
 
This activity is approved for credit by the American Society of Radiologic Technologists (ASRT) for 11/5/2019 to 12/1/2020.
 
This activity may be available in multiple formats or from different sponsors. ASRT regulations state that an individual may not repeat a self-learning activity for credit if it was reported in the same or any subsequent biennium.

Course Originally Released on: 11/13/2014
Date of Most Recent Review: 10/24/2019
Course Termination/Update Date: 10/24/2022

Unless stated above, the planners and authors of this course have declared no relevant conflicts of interest that relate to this educational activity. Relias LLC guarantees this educational activity is free from bias.

Please see CE Course Instructions to learn how to earn CE credit for this module.

Sort By
Robin S - modesto , CA  ·  Nov 15, 2019
great information - learned more about chemo therapy
Was this review helpful?  0
 
ONLINE
Price: $10.00
CE-PRO Price: $5.00